Ruiz-Rodríguez Antonio J, Molina-Vallejo Maria P, Aznar-Peralta Inés, González Puga Cristina, Cañas García Inés, González Encarna, Lorente Jose A, Serrano M Jose, Garrido-Navas M Carmen
Clinical Management Unit of Digestive Disease, San Cecilio University Hospital, 18016 Granada, Spain.
GENYO Centre for Genomics and Oncological Research: Pfizer, University of Granada, Andalusian Regional Government, Liquid Biopsy and Cancer Interception Group, PTS Granada, 18016 Granada, Spain.
Cancers (Basel). 2021 Dec 20;13(24):6386. doi: 10.3390/cancers13246386.
The isolation of circulating tumour cells (CTCs) in colorectal cancer (CRC) mostly relies on the expression of epithelial markers such as EpCAM, and phenotypic characterisation is usually performed under fluorescence microscopy with only one or two additional markers. This limits the ability to detect different CTC subpopulations based on multiple markers. The aim of this work was to develop a novel protocol combining two platforms (IsoFlux and ImageStream) to improve CTC evaluation. Cancer cell lines and peripheral blood from healthy donors were used to evaluate the efficiency of each platform independently and in combination. Peripheral blood was extracted from 16 early CRC patients (before loco-regional surgery) to demonstrate the suitability of the protocol for CTC assessment. Additionally, peripheral blood was extracted from nine patients one month after surgery to validate the utility of our protocol for identifying CTC subpopulation changes over time. Results: Our protocol had a mean recovery efficiency of 69.5% and a limit of detection of at least four cells per millilitre. We developed an analysis method to reduce noise from magnetic beads used for CTC isolation. CTCs were isolated from CRC patients with a median of 37 CTCs (IQ 13.0-85.5) at baseline. CTCs from CRC patients were significantly ( < 0.0001) larger than cytokeratin (CK)-negative cells, and patients were stratified into two groups based on BRAF and PD-L1 expression on CK-positive cells. The changes observed over time included not only the number of CTCs but also their distribution into four different subpopulations defined according to BRAF and PD-L1 positivity. We developed a novel protocol for semi-automatic CTC isolation and phenotypic characterisation by combining two platforms. Assessment of CTCs from early CRC patients using our protocol allowed the identification of two clusters of patients with changing phenotypes over time.
结直肠癌(CRC)中循环肿瘤细胞(CTC)的分离大多依赖于上皮标志物(如EpCAM)的表达,且表型特征分析通常在荧光显微镜下仅使用一两种额外标志物进行。这限制了基于多种标志物检测不同CTC亚群的能力。本研究的目的是开发一种结合两个平台(IsoFlux和ImageStream)的新方案,以改进CTC评估。使用癌细胞系和健康供者的外周血分别独立及联合评估每个平台的效率。从16例早期CRC患者(局部区域手术前)采集外周血,以证明该方案用于CTC评估的适用性。此外,在手术后1个月从9例患者采集外周血,以验证我们的方案用于识别随时间变化的CTC亚群的效用。结果:我们的方案平均回收效率为69.5%,检测限为每毫升至少4个细胞。我们开发了一种分析方法以减少用于CTC分离的磁珠产生的噪声。从CRC患者中分离出的CTC在基线时中位数为37个(四分位间距13.0 - 85.5)。CRC患者的CTC明显(<0.0001)大于细胞角蛋白(CK)阴性细胞,并且根据CK阳性细胞上的BRAF和PD-L1表达将患者分为两组。随时间观察到的变化不仅包括CTC的数量,还包括它们根据BRAF和PD-L1阳性分为四个不同亚群的分布情况。我们通过结合两个平台开发了一种用于半自动CTC分离和表型特征分析的新方案。使用我们的方案对早期CRC患者的CTC进行评估,能够识别出两组表型随时间变化的患者。